Our precinct is driving life-changing innovation in biotechnology, connecting research excellence with global industry partners like Sanofi to improve human health. From platform diagnostic technologies to precision therapies, we support the full biotechnology pipeline, from bench to bedside.
Innovation + Discovery =
Breakthroughs
Innovation & Research Strengths
From breakthrough vaccines to regenerative therapies, we’re building one of Australia’s most dynamic biotech ecosystems, powered by world-class research, collaborative infrastructure and global industry partnerships.
Our focus is on solving some of the world’s biggest health challenges through:
- Precision medicine and targeted therapies
- Drug discovery and vaccine development
- Gene and RNAi-based therapeutics
- Regenerative medicine and neurorepair
- Spatial profiling, synthetic biology and diagnostic interventions
At the heart of our work is the Institute for Biomedicine and Glycomics (IBG) at Griffith University, home to more than 400 researchers, 17 principal research leaders and several globally connected research centres, including:
- ACRF International Centre for Cancer Glycomics
- Fraunhofer Item & IBG Joint Laboratory for Anti-infective Research
- Clem Jones Centre for Neurobiology and Stem Cell Research
- National Centre for Neuroimmunology and Emerging Diseases
- Griffith Biomedicine Foundry and Bioseparations for synthetic biology and RNA-based therapies
- Ramaciotti Mass Spectrometry Platform for natural product discovery
- Unique BioBanks, including Compounds Australia, NatureBank and Saliva Bank
- NanoString Centre of Excellence in Spatial Biology
Griffith University partners in the $230 million Translational Science Hub with global vaccine company Sanofi, the Queensland Government and University of Queensland, putting us at the frontline of next-gen mRNA vaccine development.
Our research leads are driving innovations across infectious disease, cancer, neurodegenerative conditions and complex chronic illnesses like ME/CFS and Long Covid.
We don’t just do the science, we take it to the world.
Global Industry & Research Connections
Innovation thrives through collaboration
We collaborate with global and national leaders who share our commitment to impact and innovation, including:

Sanofi
Through our Translational Science Hub

Gene Company (Taiwan)
Developing RNAi-based COVID-19 therapeutics

Viome (US)
Saliva diagnostics commercialisation

Paradigm Biopharma & Limmatech Biologics
Co-development partnerships
Whether you’re a biotech investor, commercial partner or a researcher ready to scale, our doors are open.
From Concept to Commercialisation
We don’t just support innovation. We help launch it.
Whether you’re a startup with a novel therapy or a global company seeking commercial trial capacity, we offer clear pathways to bring your ideas to market. Our support spans the full biotech lifecycle, from proof of concept to commercialisation.
- Proof of Concept & Early Validation
We offer a comprehensive suite of support for early-stage biotech ventures, including:
- Access to advanced analytical platforms (e.g. NMR, mass spec, flow cytometry, confocal microscopy)
- Connections to leading researchers in immunology, oncology, infectious disease and glycomics
- Project design input and feasibility support for lab-based or in vitro validation
- Preclinical proof-of-concept pipelines and specialised lab environments
- Support for assay development, IP protection and licensing through Griffith Enterprise
- Commercial mentoring and pitch support via programs like NextGen, LuminaX and AmplifyTech
- Shared access to wet labs and co-working spaces
- Investor connections and non-dilutive grant pathways
- Clinical and regulatory partner introductions for downstream planning
Biotech companies based in the precinct can tap into a high-quality translational ecosystem, built to fast-track R&D and support commercial success.
- Clinical Engagement & Pilot
We help you engage early with clinicians and patients to ensure clinical relevance and commercial alignment. We can:
- Connect you with clinicians across 40+ specialties at Gold Coast University Hospital
- Facilitate pilot studies in real-world clinical settings (acute, rehab, community)
- Provide access to diverse patient groups via Griffith Health Clinics and allied health networks
- Enable co-design and usability testing with multidisciplinary teams
- Support prototype testing in a high-fidelity simulated hospital environment
- Integrate digital tools with live health platforms and EHR systems
- Help define clinical endpoints and outcome measures
- Navigate ethics and governance pathways for smooth pilot initiation
- Advise on collecting real-world evidence for regulatory and reimbursement success
- Link you with clinical trial infrastructure and investigator networks
Our unique environment accelerates pilot delivery, provides meaningful clinical input, and lays the foundation for scale-up.
- Ethics & Clinical Trials
We provide end-to-end support to take your innovation from concept to clinical validation with confidence. We can:
- Guide ethics and governance approvals via a nationally accredited HREC with fast-track, multi-site review
- Support Phase I–IV trials through our full-service Clinical Trials Unit
- Offer access to a purpose-built Clinical Research Facility within Gold Coast University Hospital
- Assist with protocol design, feasibility, and regulatory documentation
- Connect you with clinical investigators and trial-ready teams in key therapeutic areas
- Facilitate patient recruitment across diverse hospital and community networks
- Provide lab services (biobanking, PK, immunology) through the Institute for Biomedicine & Glycomics
- Ensure GCP compliance via dedicated coordination and data management
- Enable early assessments of safety, efficacy, and tolerability in accredited settings
- Link you with academic collaborators for translational insights
Our integrated ecosystem ensures global-quality clinical trials with the rigour to support regulatory success.
- Scaling & Commercial Readiness
We support biotech companies as they scale toward commercial launch with access to specialised infrastructure, expertise, and regulatory guidance. We can:
- Provide GMP-compliant cleanrooms for pilot-scale biologics, diagnostics, and cell/gene therapy production
- Support formulation, process optimisation, and analytics via the Griffith Analytical & Formulation Laboratory
- Assist with stability testing, release specs, and regulatory-ready documentation
- Enable prototyping of delivery devices and integrated platforms through Griffith PRECISE
- Offer usability testing and simulated clinical environments for human factors validation
- Connect you with regulatory experts to shape market authorisation strategies
- Facilitate GMP-readiness assessments and quality system development
- Link you with CRO/CDMOs and manufacturing partners for scale-up
- Help prepare technical dossiers and validation reports for TGA, FDA, or EMA
- Provide pathways to investors, mentors, and scale-up programs
We provide your biotech venture with the tools to streamline production, reduce risk, and accelerate market readiness.
- Market Access & Industry Integration
We help biotech companies overcome commercialisation barriers and scale locally and globally through deep industry and health system engagement. We can:
- Facilitate direct access to clinicians, health leaders, and procurement teams via the Gold Coast Health Innovation Office
- Support real-world validation through embedded hospital and community testbeds
- Connect you with export and trade support via Trade & Investment Queensland and INVEST Gold Coast
- Provide access to national commercialisation programs, investors, and regulatory guidance through LSQ and MTPConnect
- Assist with reimbursement strategy via Griffith’s Centre for Health Economics
- Help demonstrate clinical and economic value to payers, providers, and policymakers
- Enable participation in trade missions, global partnerships, and market expansion initiatives
- Support regulatory compliance and health technology assessments
- Offer mentoring, industry connections, and market access support
Through these partnerships and programs, we help position your venture for sustainable growth and long-term success in Australia and international markets.
We offer a comprehensive suite of support for early-stage biotech ventures, including:
- Access to advanced analytical platforms (e.g. NMR, mass spec, flow cytometry, confocal microscopy)
- Connections to leading researchers in immunology, oncology, infectious disease and glycomics
- Project design input and feasibility support for lab-based or in vitro validation
- Preclinical proof-of-concept pipelines and specialised lab environments
- Support for assay development, IP protection and licensing through Griffith Enterprise
- Commercial mentoring and pitch support via programs like NextGen, LuminaX and AmplifyTech
- Shared access to wet labs and co-working spaces
- Investor connections and non-dilutive grant pathways
- Clinical and regulatory partner introductions for downstream planning
Biotech companies based in the precinct can tap into a high-quality translational ecosystem, built to fast-track R&D and support commercial success.
We help you engage early with clinicians and patients to ensure clinical relevance and commercial alignment. We can:
- Connect you with clinicians across 40+ specialties at Gold Coast University Hospital
- Facilitate pilot studies in real-world clinical settings (acute, rehab, community)
- Provide access to diverse patient groups via Griffith Health Clinics and allied health networks
- Enable co-design and usability testing with multidisciplinary teams
- Support prototype testing in a high-fidelity simulated hospital environment
- Integrate digital tools with live health platforms and EHR systems
- Help define clinical endpoints and outcome measures
- Navigate ethics and governance pathways for smooth pilot initiation
- Advise on collecting real-world evidence for regulatory and reimbursement success
- Link you with clinical trial infrastructure and investigator networks
Our unique environment accelerates pilot delivery, provides meaningful clinical input, and lays the foundation for scale-up.
We provide end-to-end support to take your innovation from concept to clinical validation with confidence. We can:
- Guide ethics and governance approvals via a nationally accredited HREC with fast-track, multi-site review
- Support Phase I–IV trials through our full-service Clinical Trials Unit
- Offer access to a purpose-built Clinical Research Facility within Gold Coast University Hospital
- Assist with protocol design, feasibility, and regulatory documentation
- Connect you with clinical investigators and trial-ready teams in key therapeutic areas
- Facilitate patient recruitment across diverse hospital and community networks
- Provide lab services (biobanking, PK, immunology) through the Institute for Biomedicine & Glycomics
- Ensure GCP compliance via dedicated coordination and data management
- Enable early assessments of safety, efficacy, and tolerability in accredited settings
- Link you with academic collaborators for translational insights
Our integrated ecosystem ensures global-quality clinical trials with the rigour to support regulatory success.
We support biotech companies as they scale toward commercial launch with access to specialised infrastructure, expertise, and regulatory guidance. We can:
- Provide GMP-compliant cleanrooms for pilot-scale biologics, diagnostics, and cell/gene therapy production
- Support formulation, process optimisation, and analytics via the Griffith Analytical & Formulation Laboratory
- Assist with stability testing, release specs, and regulatory-ready documentation
- Enable prototyping of delivery devices and integrated platforms through Griffith PRECISE
- Offer usability testing and simulated clinical environments for human factors validation
- Connect you with regulatory experts to shape market authorisation strategies
- Facilitate GMP-readiness assessments and quality system development
- Link you with CRO/CDMOs and manufacturing partners for scale-up
- Help prepare technical dossiers and validation reports for TGA, FDA, or EMA
- Provide pathways to investors, mentors, and scale-up programs
We provide your biotech venture with the tools to streamline production, reduce risk, and accelerate market readiness.
We help biotech companies overcome commercialisation barriers and scale locally and globally through deep industry and health system engagement. We can:
- Facilitate direct access to clinicians, health leaders, and procurement teams via the Gold Coast Health Innovation Office
- Support real-world validation through embedded hospital and community testbeds
- Connect you with export and trade support via Trade & Investment Queensland and INVEST Gold Coast
- Provide access to national commercialisation programs, investors, and regulatory guidance through LSQ and MTPConnect
- Assist with reimbursement strategy via Griffith’s Centre for Health Economics
- Help demonstrate clinical and economic value to payers, providers, and policymakers
- Enable participation in trade missions, global partnerships, and market expansion initiatives
- Support regulatory compliance and health technology assessments
- Offer mentoring, industry connections, and market access support
Through these partnerships and programs, we help position your venture for sustainable growth and long-term success in Australia and international markets.
Purpose-Built Infrastructure
We support end-to-end biotech innovation through our advanced facilities:
- IBG and associated research centres across Griffith campuses
- Custom wet and dry labs within Lumina and Cohort Innovation Space
- Extensive clinical trials facilities (Phase I – IV)
- Access to unique biobank resources: Gold Coast Biobank, Compounds Australia, NatureBank, Saliva Bank, and Neurobank
- Specialist equipment including Australia’s only native mass spectrometry platform
Talent & Workforce Pipeline
Future-ready biotech talent is right here and ready to collaborate.
We work closely with Griffith University, industry and clinical partners to build a strong and adaptable workforce for the biotech sector.
Here’s how we help you connect with talent:
- Student placements and research collaborations, from honours to PhD.
- Specialist programs in biomedical science, clinical research, translational health and gene therapies.
- Access to graduates, postdocs and early-career researchers already embedded in the precinct.
- Work-integrated learning and co-designed training for lab, commercial and clinical roles.
Gold Coast Advantage
Australia’s lifestyle capital is now a global biotech destination.
Locating your biotech venture on the Gold Coast means more than just great weather. It means immediate access to research partners, hospital networks and international pathways.
- Co-location with researchers, clinicians and commercial trial partners
- A growing innovation ecosystem with business support
- A talent magnet—the lifestyle helps attract and retain skilled professionals
- Commercial-ready leasing in Lumina
- Regional incentives